9 results
424B5
CRSP
CRISPR Therapeutics AG
21 Sep 18
Prospectus supplement for primary offering
4:10pm
to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines, or imprisonment.
Efforts to ensure
424B5
k4b6xhdd1y2s3gngb
19 Sep 18
Prospectus supplement for primary offering
4:21pm
10-K
7drx477r8h7fm34jmf6m
10 Mar 17
Annual report
12:00am
10-Q
grgf93z3rgozxqyfn gh
22 Nov 16
Quarterly report
12:00am
- Prev
- 1
- Next